Hyaluronidase

Hyaluronidase is a family of enzymes that catalyze the hydrolysis of hyaluronic acid (hyaluronan), a high-molecular-weight glycosaminoglycan that forms part of the extracellular matrix. By cleaving hyaluronic acid, hyaluronidase reduces the viscosity of intercellular matrices and increases tissue permeability, facilitating the spread of fluids, drugs, or microorganisms through connective tissues.

In humans, several hyaluronidases have been identified, including HYAL1, HYAL2, HYAL3, HYAL4, and the testis‑specific PH20 (also known as SPAM1). HYAL2 is a membrane-anchored enzyme that initiates degradation of hyaluronic acid at the cell surface, while HYAL1 functions optimally in acidic lysosomal environments to complete HA breakdown. HYAL4 has activity on other glycosaminoglycans, and PH20 is expressed in sperm and plays a role in fertilization. The hyaluronidases contribute to normal tissue remodeling, development, and fertility, and they can be exploited by pathogens to aid invasion.

Clinically, hyaluronidase is used as a spreading factor to enhance the dispersion and absorption of injected drugs and local anesthetics in subcutaneous tissue. It is also employed in aesthetic medicine to dissolve hyaluronic acid fillers and in ophthalmic or perioperative contexts to facilitate diffusion of solutions. Commercial preparations include recombinant human hyaluronidase and various animal-derived forms, with dosing and indications varying by product and clinical situation. Adverse effects can include localized swelling, redness, and allergic reactions; there is potential for hypersensitivity, particularly with nonhuman or bovine-derived preparations.

Microbially produced hyaluronidases function as virulence factors, enabling bacteria to degrade extracellular matrix and spread through tissues during infection. This enzymatic activity is a key contributor to pathogenesis in some invasive bacterial diseases.